Recovery from idiopathic facial paralysis: Prednisolone or prednisolone / acyclovir?

Recuperación de parálisis facial idiopática: ¿Prednisolona o prednisolona/aciclovir?

There is discrepancy in literature regarding the treatment of idiopathic facial palsy. Insufficient evidence is available supporting combined therapy with anti-viral drugs and systemic corticosteroids; however, this regime is frequently used in clinical practice justified by probable viral etiology. Objective: to describe frequency offull recovery in patients who received prednisolone alone or prednisolone/acyclovir combined therapy. Metlwds: this is a historie cohort trial identifying the cases of peripheral facial palsy diagnosed between January 2005 and January 2009 by a review of otolaryngology records. Palsy was classified at admission using the House-Brackmann grading scale. Results: 106 cases were studied, 59 females (55.7%) and 47 males (44.3%), with a mean age of 36.9 years (SD 16.7). At admission, 47.2% presented grade III palsy. Prednisolone was administered to 32 (30.2%) and 74 (69.8%) received prednisolone-acyclovir. Complete recovery (House-Brackmann Grade I) was documented in 23 (71.9%) prednisolone-treated-patients and in 52 (70.2 % ) prednisolone/acyclovir-treated-patients. Mean follow-up was 39 days. The improvement profile in both groups was better in patients with grades II and III palsy at admission. Conclusion: improvement is greater to that described for a placebo, but less than expected for a 3-month administration of prednisolone. The rate of complete recovery was similar in both groups. Data cannot be compared with other publications due to the short follow-up period in this trial.

1. Williamson IG, Whelan TR. Toe clinical problemofBell's palsy: is treatment with steroids effective?. Br J Gen Pract.1996 Dec; 46(413): 743-47.
2. Santos Lasaosa S, Pascual Millan LF, Tejero Juste C, Morales Asín F. Páralisis facial periférica: etiología, diagnostico y tratamiento. Rev Neurol. 2000; 30(11): 1048-53.
3. Ramsey MJ, DerSimonian R, Holtel MR, Burgess LP. Corticosteroid treatment for ldiopatbic facial nerve paralysis: a meta-analysis. Laryngoscope. 2000 Mar; l 10(3 Pt 1):335-41.
4. Adour KK, Bell DN, Hilsinger RL Jr.Herpes simplex virus in idiopathic facial paralysis ( Bell palsy). JAMA. 1975 Aug 11; 233 (6): 527-30
5. PeitersenE.Toe natural history ofBells palsy. Acta otolaryngol. 1992; 492:122 24.
6. Adour KK, et al. Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled tria!. Ann oto! Rhinol Laryngol. 1996 may; 105 (5): 371-8.
7. Ramos Macias A, De Miguel Matinez l.The incorporation of acyclovir into the treatment ofperipheral paralysis. A study of45 cases. Acta Otorrinolaringol Esp. 1992 Mar Apr; 43(2): 117-20.
8. De DiegoJl, PrirnMP.ldiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily. Laryngoscope. 1998 Apr; 108(4 Pt 1):573-5.
9. Sullivan FM, Swan IR, Donnan PT, et al.Early treatment with prednisolone or aciclovir in Bell's palsy. N Engl J Med. 2007 Oct l8;357(16):1598-607.
10. Hato N, Yamada H, Kohno H, et al. Valacyclovir and prednisolonetreatment for Bell's palsy: a multicenter, randomized,placebo-controlled study. Oto! Neurotol.2007;28(3):408-13.